0 A peek behind the paper – Mohammad K Parvez on coronaviral hepatitis
In an exclusive interview with an author behind one of the papers published in the recent Future Virology Special Focus Issue, heptatitis and COVID-19 are discussed.
Browsing: Basic > Pathology & Pathogenesis
0 Why do pediatric patients tend to avoid the worst coronavirus complications?
Differences in lung physiology and immune function in children may lie behind their decreased rates of symptomatic infections, hospitalization and death, according to a study from The University of Texas and Baylor College of Medicine (both TX, USA).
0 Top ten articles on COVID-19
As we continue to further our understanding of the novel coronavirus, its epidemiological characteristics, associated risk factors and possible avenues for treatment, take a look at the top 10 most-read articles so far on COVID-19.
0 International NETwork investigates the role of neutrophils in severe COVID-19 cases
A global research consortium has provided new evidence suggesting that neutrophils may be responsible for severe symptoms linked to COVID-19.
0 A peek behind the paper – Muhammad Faheem on dengue virus proteins as potential drug targets
Take a look behind the scenes of a recent Future Virology editorial entitled, ‘An insight into dengue virus proteins as potential drug/vaccine targets’, as we ask author Muhammad Faheem about recent advances in understanding dengue proteins and where the next 5–10 years could take us.
0 The role of humoral immunity in TB defense – an interview with Babak Javid
Emerging evidence has suggested that B cells and humoral immunity could modulate the immune response to intracellular pathogens. We speak to Babak Javid about his research on this topic and the importance of learning about immune factors in order to develop vaccination strategies and to understand latent TB.
0 AGO4: a potential new universal target for antiviral therapeutics
A team of researchers have uncovered a protein, AGO4, which may have the potential to be used as a therapeutic target to universally increase protection against viral pathogens.
2 Novel parasites and understanding parasite–host interactions – an interview with Sandra Maruyama
In October 2019 researchers from Brazil identified a new parasite, which presented with similar symptoms to visceral leishmaniasis. To discover more about this novel parasite and other parasitic diseases in Brazil, we interviewed Sandra Maruyama from the Federal University of São Carlos (UFSCar; São Paulo, Brazil) about her research and the future of this field.
0 A peek behind the paper – Elvira Román on CRISPR technology in pathogenic fungi
Take a look behind the scenes of a recent Future Microbiology article, entitled ‘New insights of CRISPR technology in pathogenic fungi’, as we ask author Elvira Román (Complutense University of Madrid, Spain) about the advances CRISPR technology has already brought to this field and the potential it could hold in the future.
6 COVID-19: latest news and figures
The WHO has declared that the COVID-19 outbreak can be characterized as a pandemic as new cases are reported globally, including a huge spike in cases in South Korea, Italy and Iran and over 100 other countries reporting cases.
